|
Cytoplasmic Granules
|
D003594 |
[Condensed areas of cellular material that may be bounded by a membrane.
] |
|
Cytoplasmic Streaming
|
D003595 |
[The movement of CYTOPLASM within a CELL. It serves as an internal transport system for moving essential substances throughout the cell, and in single-celled organisms, such as the AMOEBA, it is responsible for the movement (CELL MOVEMENT) of the entire cell.
] |
|
Cytoplasmic Structures
|
D022083 |
[Components of the cytoplasm excluding the CYTOSOL.
] |
|
Cytoplasmic Vesicles
|
D022162 |
[Membrane-limited structures derived from the plasma membrane or various intracellular membranes which function in storage, transport or metabolism.
] |
|
Cytoprotection
|
D019610 |
[The process by which chemical compounds provide protection to cells against harmful agents.
] |
|
Cytoreduction Surgical Procedures
|
D065426 |
[Operative procedures carried out to reduce a mass of tissue, for example, to reduce the total amount of tissue composing a tumor.
] |
|
Cytosine
|
D003596 |
[A pyrimidine base that is a fundamental unit of nucleic acids.
] |
|
Cytosine Deaminase
|
D043525 |
[An enzyme which catalyzes the deamination of CYTOSINE resulting in the formation of URACIL. It can also act on 5-methylcytosine to form THYMIDINE.
] |
|
Cytosine Nucleotides
|
D003597 |
[A group of pyrimidine NUCLEOTIDES which contain CYTOSINE.
] |
|
Cytoskeletal Proteins
|
D003598 |
[Major constituent of the cytoskeleton found in the cytoplasm of eukaryotic cells. They form a flexible framework for the cell, provide attachment points for organelles and formed bodies, and make communication between parts of the cell possible.
] |
|
Cytoskeleton
|
D003599 |
[The network of filaments, tubules, and interconnecting filamentous bridges which give shape, structure, and organization to the cytoplasm.
] |
|
Cytosol
|
D003600 |
[Intracellular fluid from the cytoplasm after removal of ORGANELLES and other insoluble cytoplasmic components.
] |
|
Cytostatic Agents
|
D054697 |
[Compounds that inhibit or prevent the proliferation of CELLS.
] |
|
Cytotoxicity Tests, Immunologic
|
D003601 |
[The demonstration of the cytotoxic effect on a target cell of a lymphocyte, a mediator released by a sensitized lymphocyte, an antibody, or complement.
] |
|
Cytotoxicity, Immunologic
|
D003602 |
[The phenomenon of target cell destruction by immunologically active effector cells. It may be brought about directly by sensitized T-lymphocytes or by lymphoid or myeloid "killer" cells, or it may be mediated by cytotoxic antibody, cytotoxic factor released by lymphoid cells, or complement.
] |
|
Cytotoxins
|
D003603 |
[Substances that are toxic to cells; they may be involved in immunity or may be contained in venoms. These are distinguished from CYTOSTATIC AGENTS in degree of effect. Some of them are used as CYTOTOXIC ANTIBIOTICS. The mechanism of action of many of these are as ALKYLATING AGENTS or MITOSIS MODULATORS.
] |
|
Czech Republic
|
D018153 |
[Created 1 January 1993 as a result of the division of Czechoslovakia into the Czech Republic and Slovakia.
] |
|
Czechoslovakia
|
D003604 |
[Created as a republic in 1918 by Czechs and Slovaks from territories formerly part of the Austro-Hungarian Empire. The country split into the Czech Republic and Slovakia 1 January 1993.
] |
|
D-Ala(2),MePhe(4),Met(0)-ol-enkephalin
|
D005405 |
[A stable synthetic analog of methionine enkephalin (ENKEPHALIN, METHIONINE). Actions are similar to those of methionine enkephalin. Its effects can be reversed by narcotic antagonists such as naloxone.
] |
|
D-Alanine Transaminase
|
D051263 |
[A PYRIDOXAL PHOSPHATE containing enzyme that catalyzes the reversible transfer of an amino group between D-Alanine and alpha-ketoglutarate to form PYRUVATE and D-GLUTAMATE, respectively. It plays a role in the synthesis of the bacterial CELL WALL. This enzyme was formerly classified as EC 2.6.1.10.
] |
